OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Ronald Crystal

2 Projects | 1 Researchers | $4,006,472 Invested

2017

Weill Medical College of Cornell University

Ronald Crystal, MD

Phase I study of an AAVrh.10-mediated Apolipoprotein E2 Gene Delivery to the CNS for the treatment of Alzheimer's Disease in E4 Homozygotes .

  • Funding Amount: $3,006,472
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: zzAPOE
  • Status: Active

2014

Weill Medical College of Cornell University

Ronald Crystal, MD

Translation to the Clinic of AAVrh.10-mediated Delivery to the CNS of the Apolipoprotein E2 Gene for Treatment of Alzheimer's Disease

  • Funding Amount: $1,000,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: zzAPOE
  • Status: Closed